Article | March 31, 2021

Top Ten Rules For Success In Decentralized Trials

Source: Parexel

By Guido Epple, Innovation Ambassador and Head of Clinical Trial, Supplies & Logistics Product Management; Alexandra Holzum, Associate Director, Integrated Solutions, Clinical Trial, Supplies & Logistics; Julia Lakeland, Solutions Architect and Program Director; Sarah Pilkington, Associate Director, Patient Innovation Center; Ada Wowk, Director, Patient Innovation Center; Parexel®

Top 10 ten iStock-670634444

The global coronavirus pandemic catapulted the emerging field of decentralized clinical trials (DCTs) to the forefront of clinical research in a matter of months. With approaches like home nursing, telehealth, direct-to-patient (DTP) drug shipments, and mobile sensors, DCTs are making it easier for patients to participate in trials, especially for those who live far away, are too sick to travel, or are too busy.

Parexel’s DCT experience spans more than 100 fully decentralized or hybrid trials, and more than 250 trials with DTP drug shipments. Patients’ needs and insights are central to how we design and conduct trials, so we talked with Parexel DCT experts to find out what they have learned. Here are their top ten rules for a successful DCT.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: